Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of metabolic disorders. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://zubairusmi396051.blogofchange.com/39651851/trelaglutide-exploring-a-new-option-for-chronic-diseases